Terms: = Colorectal cancer AND TRB
11 results:
1. Decoding the transcriptional heterogeneity, differentiation lineage, clinical significance in tissue-resident memory CD8 T cell of the small intestine by single-cell analysis.
Fang J; Lei J; He B; Wu Y; Chen P; Sun Z; Wu N; Huang Y; Wei P; Yin L; Chen Y
J Transl Med; 2024 Feb; 22(1):203. PubMed ID: 38403590
[TBL] [Abstract] [Full Text] [Related]
2. Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic colorectal cancer.
Xu M; Tsunedomi R; Kiyotani K; Tomochika S; Furuya K; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Anticancer Res; 2023 Feb; 43(2):613-620. PubMed ID: 36697107
[TBL] [Abstract] [Full Text] [Related]
3. Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.
Xu Y; Morales AJ; Cargill MJ; Towlerton AMH; Coffey DG; Warren EH; Tykodi SS
Cancer Immunol Immunother; 2019 Dec; 68(12):1979-1993. PubMed ID: 31686124
[TBL] [Abstract] [Full Text] [Related]
4. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
[TBL] [Abstract] [Full Text] [Related]
5. Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling.
Serafino A; Moroni N; Psaila R; Zonfrillo M; Andreola F; Wannenes F; Mercuri L; Rasi G; Pierimarchi P
Biochim Biophys Acta; 2012 Jun; 1822(6):1004-18. PubMed ID: 22387884
[TBL] [Abstract] [Full Text] [Related]
6. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P
Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216
[TBL] [Abstract] [Full Text] [Related]
7. Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats.
Otto J; Jansen PL; Lucas S; Schumpelick V; Jansen M
BMC Cancer; 2007 Jun; 7():104. PubMed ID: 17584925
[TBL] [Abstract] [Full Text] [Related]
8. In vitro thermochemotherapy of colon cancer cell lines with irinotecan alone and combined with mitomycin C.
Le Page S; Kwiatkowski F; Paulin C; Mohamed F; Pezet D; Chipponi J; Benhamed M; Gilly FN; Glehen O
Hepatogastroenterology; 2006; 53(71):693-7. PubMed ID: 17086870
[TBL] [Abstract] [Full Text] [Related]
9. Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy.
Braumann C; Ordemann J; Kilian M; Wenger FA; Jacobi CA
Clin Exp Metastasis; 2003; 20(5):387-94. PubMed ID: 14524527
[TBL] [Abstract] [Full Text] [Related]
10. Expression of human tumor mucin-associated carbohydrate epitopes, including sialylated Tn, and localization of murine monoclonal antibodies CC49 and B72.3 in a syngeneic rat colon carcinoma model.
O'Boyle KP; Goya V; Zuckier LS; Chun S; Bhargava K
J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):251-61. PubMed ID: 7533599
[TBL] [Abstract] [Full Text] [Related]
11. Mechanisms of resistance of confluent human and rat colon cancer cells to anthracyclines: alteration of drug passive diffusion.
Pelletier H; Millot JM; Chauffert B; Manfait M; Genne P; Martin F
Cancer Res; 1990 Oct; 50(20):6626-31. PubMed ID: 2208125
[TBL] [Abstract] [Full Text] [Related]
